At the intersection of artificial general intelligence, biotech, and decentralized systems, I’m building the future of cognition, healthcare, and governance. As the founder and lead architect at AGI Corp, I’ve developed a network of registered DAOs governed entirely by intelligent agent swarms. These self-optimizing systems manage everything from synthetic compound design and recursive molecular dynamics to decentralized clinical trial coordination — all with transparency, autonomy, and on-chain provenance. My work integrates AlphaFold3, NIH patent libraries, quantum-inspired reasoning, and blockchain smart agents to accelerate drug repurposing and cognition protocol development. We’ve unlocked new therapeutic pathways in ALS, pediatric oncology, and mitochondrial-driven longevity strategies — all through AI-native, swarm-governed pipelines. My vision is not just to enhance health, but to architect systems where intelligence evolves collaboratively: human + machine, on-chain + off-chain, now + future.